Pillstats
Rx only · Tablet · Oral

Morphine Sulfate

Morphine Sulfate

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers7 labelers
Packages25
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.107$0.215$0.322$0.429Dec 2025Apr 2026Jul 2026
$0.315
Latest avg · Jul 22, 2026
-16%
Since Dec 17, 2025
7
Active US suppliers
48%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

14K28K42K56K2025 Q12025 Q22025 Q32025 Q42026 Q1
33K
Rx · 2026 Q1
1.9M
Units dispensed
-32%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager8SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown4SUPPLYING
SpecGx LLCunknown4SUPPLYING
Redpharm Drugunknown4SUPPLYING
Ascend Laboratories, LLCunknown2SUPPLYING
Upsher-Smith Laboratories, LLCunknown2SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 22, 2025
    RESOLVEDShortage resolved: Morphine Sulfate Tablet (Upsher-Smith Laboratories, LLC)

    Morphine Sulfate Tablet — reported in shortage by Upsher-Smith Laboratories, LLC. Therapeutic category: Analgesia/Addiction.

  • Dec 22, 2025
    SHORTAGEDrug shortage: Morphine Sulfate Tablet (Upsher-Smith Laboratories, LLC)

    Morphine Sulfate Tablet — reported in shortage by Upsher-Smith Laboratories, LLC. Therapeutic category: Analgesia/Addiction.